AI-driven drug discovery represents a transformative approach that leverages artificial intelligence to expedite the identification and development of new medications. This technology enhances the prediction of drug interactions, personalizes treatment options, and reduces costs, all while integrating diverse data sources and enabling the repurposing of existing drugs. By significantly advancing traditional methods, AI in drug discovery primarily benefits pharmaceutical companies, researchers, and healthcare providers focused on improving the efficiency and effectiveness of drug development processes.
